跳至主要内容
临床试验/NCT07073937
NCT07073937Enrolling By Invitation不适用

Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty

University of Utah1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
100
试验地点
1
主要终点
Percentage of surgical success at three years.

研究概览

简要总结

The goal of this study is to learn if combining minimally invasive glaucoma surgery (MIGS) procedures with different mechanisms of action increases the effectiveness of MIGS. The main question the study aims to answer is: Does combining viscodilation (a surgical technique, often used in glaucoma treatment, that involves using a high-viscosity, elastic gel to widen and open the Schlemm's canal, a main drainage channel in the eye) with the iTrack catheter, along with the Hydrus microstent, show better reduction in intraocular pressure than cataract surgery alone? Researchers will retrospectively review charts of patients who have open-angle glaucoma who have undergone combination Hydrus implantation and 360-degree iTrack canaloplasty with concomitant cataract surgery, who have at least 36 months of clinical follow-up data. Baseline demographic information and severity of glaucoma will be recorded, as will change from baseline yearly to three years in average optical coherence tomography (OCT) retina nerve fiber layer (RNFL) measurements and visual field (VF) pattern standard deviation. Safety outcomes and the percentage of eyes requiring secondary surgical intervention will be recorded at yearly time points.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with open angle glaucoma (mild, moderate or severe as defined below) who have undergone combined Hydrus and 360 degree canaloplasty with concomitant cataract surgery with at least 3-year follow-up data
  • Mild: Definite optic disc, RNFL, or macular imaging abnormalities consistent with glaucoma and a normal visual field as tested with standard automated perimetry (SAP)
  • Moderate: Definite optic disc, RNFL, or macular imaging abnormalities consistent with glaucoma, and visual field abnormalities in one hemifield that are not within 5 degrees of fixation as tested with SAP
  • Severe: Definite optic disc, RNFL, or macular imaging abnormalities consistent with glaucoma, and visual field abnormalities in both hemifields and/or loss within 5 degrees of fixation in at least one hemifield as tested with standard automated perimetry (SAP)
  • Patients who have had prior selective laser trabeculoplasty (SLT) are allowed

排除标准

  • Prior corneal graft (penetrating Keratoplasty [PKP], deep anterior lamellar keratoplasty [DALK], Descemet's Stripping Automated Endothelial Keratoplasty [DSAEK], Descemet membrane endothelial keratoplasty [DMEK]) & refractive surgery
  • Prior retinal surgery
  • Prior MIGS or incisional glaucoma surgery
  • Angle closure glaucoma and other secondary glaucoma

研究组 & 干预措施

Glaucoma patients

Patients from the Moran Eye Center who have open-angle glaucoma and have had a combination of Hydrus and 360-degree canaloplasty with concomitant cataract surgery, who have at least three years of follow-up data.

干预措施: Retrospective chart review (Other)

结局指标

主要结局

Percentage of surgical success at three years.

时间窗: From baseline to three years post-surgery

Surgical success is defined as a decrease of one or more glaucoma medications from baseline without an increase in medicated intraocular pressure (IOP).

次要结局

  • Mean decrease in IOP from baseline at three years(From baseline to three years post-surgery)
  • Mean number of medication reduction from baseline to three years(From baseline to three years post-surgery)
  • Percentage of eyes with greater than twenty percent reduction in IOP from baseline to year three(From baseline to three years post-surgery)
  • Percentage of eyes that are medication free at three years(At three years post-surgery)
  • Percentage of eyes with IOP between 14 and 18 mmHg on the same number of medications or fewer at three years post-surgery(At three years post-surgery)
  • Change in average RNFL from baseline yearly to three years(At baseline, one year, two years and three years post-surgery)
  • Change in average HVF PSD from baseline yearly to three years(At baseline, one year, two years and three years post-surgery)
  • Percentage of eyes requiring secondary surgical intervention at yearly time points(At one year, two years and three years post-surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Craig Chaya

Assistant Professor (Clinical)

University of Utah

研究点 (1)

Loading locations...

相似试验